Access Resources
2001 - 2010 of 7562 Results
Title
Year
- Radiomics in predicting recurrence for patients with locally advanced breast cancer using quantitative ultrasound2021RESTRICTEDTitle: Radiomics in predicting recurrence for patients with locally advanced breast cancer using quantitative ultrasoundJournal Name: OncotargetPublisher: Impact Journals, LLCVol: 12Issue #: 25Start Page: 2437End Page: 2448Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.18632/oncotarget.28139Best OA location URL: https://www.oncotarget.com/article/28139/pdf/Citation Count: 8
-
RESTRICTEDTitle: Investigation of USP30 inhibition to enhance Parkin-mediated mitophagy: tools and approachesJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 478Issue #: 23Start Page: 4099End Page: 4118Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1042/bcj20210508Best OA location URL: https://portlandpress.com/biochemj/article-pdf/478/23/4099/925639/bcj-2021-0508.pdfCitation Count: 25
- Pathological α-syn aggregation is mediated by glycosphingolipid chain length and the physiological state of α-syn in vivo2021RESTRICTEDTitle: Pathological α-syn aggregation is mediated by glycosphingolipid chain length and the physiological state of α-syn in vivoJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 118Issue #: 50Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1073/pnas.2108489118Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685670Citation Count: 19
- [18F]Nifene PET/CT Imaging in Mice: Improved Methods and Preliminary Studies of α4β2* Nicotinic Acetylcholinergic Receptors in Transgenic A53T Mouse Model of α-Synucleinopathy and Post-Mortem Human Parkinson’s Disease2021RESTRICTEDTitle: [18F]Nifene PET/CT Imaging in Mice: Improved Methods and Preliminary Studies of α4β2* Nicotinic Acetylcholinergic Receptors in Transgenic A53T Mouse Model of α-Synucleinopathy and Post-Mortem Human Parkinson’s DiseaseJournal Name: MoleculesPublisher: MDPI AGVol: 26Issue #: 23Start Page: 7360End Page: 7360Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/molecules26237360Best OA location URL: https://www.mdpi.com/1420-3049/26/23/7360/pdf?version=1638601226Citation Count: 14
-
RESTRICTEDTitle: GPi‐DBS for KMT2B‐Associated Dystonia: Systematic Review and Meta‐AnalysisJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: 1Start Page: 31End Page: 37Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13374Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13374Citation Count: 14
- Atlas of RNA editing events affecting protein expression in aged and Alzheimer’s disease human brain tissue2021RESTRICTEDTitle: Atlas of RNA editing events affecting protein expression in aged and Alzheimer’s disease human brain tissueJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-021-27204-9Best OA location URL: https://www.nature.com/articles/s41467-021-27204-9.pdfCitation Count: 18
-
RESTRICTEDTitle: Different rates of cognitive decline in autosomal dominant and late‐onset Alzheimer diseaseJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 18Issue #: 10Start Page: 1754End Page: 1764Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/alz.12505Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160203Citation Count: 4
-
RESTRICTEDTitle: For Some Neurologists, COVID-19 Has Prompted an ‘Existential Crisis’Journal Name: Neurology TodayPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 23Start Page: 1,22End Page: 25Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nt.0000805196.94665.beCitation Count: 0
-
RESTRICTEDTitle: How to Increase Diverse Representation in Parkinson's Disease TrialsJournal Name: Neurology TodayPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 23Start Page: 20End Page: 22Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nt.0000805216.68841.48Citation Count: 0
- Metabolic Profile in Plasma AND CSF of LEVODOPA-induced Dyskinesia in Parkinson’s Disease: Focus on Neuroinflammation2021RESTRICTEDTitle: Metabolic Profile in Plasma AND CSF of LEVODOPA-induced Dyskinesia in Parkinson’s Disease: Focus on NeuroinflammationJournal Name: Molecular NeurobiologyPublisher: Springer Science and Business Media LLCVol: 59Issue #: 2Start Page: 1140End Page: 1150Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s12035-021-02625-1Citation Count: 9